Respiratory

COVID-19 nanoMIPs for sensors B2GOF

£1,980.00

MIP Discovery’s ultra-high sensitivity COVID-19 nanoMIPs have been designed to detect the SARS-CoV-2 virus in rapid point of care devices.

Demonstrated an extremely low limit of detection of 5 fg/ml in a sensor device
20 fold improvement to sensitivity when directly compared to commercial antibodies
No cross reactivity to coronavirus variants 299E, HKU1 or OC43

Pack Size

Clear selection

Technical Specification

COVID-19 nanoMIPs for Sensors

Product Name: COVID-19 nanoMIP for sensors
Product Code: COV1001-B
Target: SARS-CoV-2 Coronavirus spike protein
Concentration: >0.1 mg/ml
Surface Functionality: Amine groups
Tested Applications: SPR, dot blot, electrochemical sensors

Documents

Performance Data

Analytical sensitivity

of <5 ng/ml in a sensor

Analytical sensitivity has been demonstrated to <5 fg/ml for the RBD spike protein in a thermal resistance sensor device.

Selectivity to SARS-CoV-2

spike protein

The SARS-CoV-2 nanoMIP has been shown to only detect SARS-CoV-2 spike Glycoprotein and not detect Human Coronavirus 299E Spike Glycoprotein, Human Coronavirus HKU1 Spike Glycoprotein and Human Coronavirus OC43 Spike Glycoprotein in Dot Blot

Excellent batch to batch

consistency

The chemical manufacturing process employed ensures batch to batch consistency and reproducibility of the SARS-CoV-2 nanoMIP.

Research use only